Arsenic trioxide

About

Therapy type: Targeted therapy

Therapy strategy: PML::RARA inhibition

Mappings

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Organization(s) Biomarker(s) Cancer type Therapy(ies)
EMA (1) FDA (2) HSE (2) PML::RARA APL with PML-RARA Arsenic trioxide
FDA (2) t(15;17) APL with PML-RARA Arsenic trioxide